These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35545048)

  • 1. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
    Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
    Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy.
    Wang L; Bi R; Li L; Zhou K; Yin H
    Aging (Albany NY); 2021 Aug; 13(15):19272-19281. PubMed ID: 34374662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m(6)A: Signaling for mRNA splicing.
    Adhikari S; Xiao W; Zhao YL; Yang YG
    RNA Biol; 2016 Sep; 13(9):756-9. PubMed ID: 27351695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
    He X; Zhang P
    Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic SRSF3 in health and diseases.
    Jia R; Zheng ZM
    Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.
    Kasowitz SD; Ma J; Anderson SJ; Leu NA; Xu Y; Gregory BD; Schultz RM; Wang PJ
    PLoS Genet; 2018 May; 14(5):e1007412. PubMed ID: 29799838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Phosphorylations of SR Protein SRSF3 and Its Binding to m
    Tatsuno T; Ishigaki Y
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1.
    Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL
    Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the expression and stability of full-length and truncated SRSF3 proteins in human cancer cells.
    Sue SH; Liu ST; Huang SM
    Sci Rep; 2024 Jun; 14(1):14397. PubMed ID: 38909100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.
    Xiong G; Liu C; Yang G; Feng M; Xu J; Zhao F; You L; Zhou L; Zheng L; Hu Y; Wang X; Zhang T; Zhao Y
    J Hematol Oncol; 2019 Sep; 12(1):97. PubMed ID: 31514732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
    Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer.
    Zheng X; Peng Q; Wang L; Zhang X; Huang L; Wang J; Qin Z
    Int J Biol Sci; 2020; 16(13):2442-2453. PubMed ID: 32760211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
    DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
    Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
    Che Y; Bai M; Lu K; Fu L
    Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer.
    Su J; Li R; Chen Z; Liu S; Zhao H; Deng S; Zeng L; Xu Z; Zhao S; Zhou Y; Li M; He X; Liu J; Xue C; Bai R; Zhuang L; Zhou Q; Zhang S; Chen R; Huang X; Lin D; Zheng J; Zhang J
    Cancer Res; 2023 Sep; 83(18):3059-3076. PubMed ID: 37326469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.